DK0680752T3 - Konditionerede vandopløselige stoffer - Google Patents

Konditionerede vandopløselige stoffer

Info

Publication number
DK0680752T3
DK0680752T3 DK95111178T DK95111178T DK0680752T3 DK 0680752 T3 DK0680752 T3 DK 0680752T3 DK 95111178 T DK95111178 T DK 95111178T DK 95111178 T DK95111178 T DK 95111178T DK 0680752 T3 DK0680752 T3 DK 0680752T3
Authority
DK
Denmark
Prior art keywords
soluble substances
conditioned water
water
vacuum
micronised
Prior art date
Application number
DK95111178T
Other languages
Danish (da)
English (en)
Inventor
Katarina Ulla Bystroem
Edib Jakupovic
Jan William Trofast
Eva Ann-Christin Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20382434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0680752(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK0680752T3 publication Critical patent/DK0680752T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK95111178T 1991-04-11 1992-03-24 Konditionerede vandopløselige stoffer DK0680752T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101090A SE9101090D0 (sv) 1991-04-11 1991-04-11 Process for conditioning of water-soluble substances

Publications (1)

Publication Number Publication Date
DK0680752T3 true DK0680752T3 (da) 2002-02-25

Family

ID=20382434

Family Applications (2)

Application Number Title Priority Date Filing Date
DK92907877.2T DK0580648T3 (da) 1991-04-11 1992-03-24 Fremgangsmåde til konditionering af vandopløselige stoffer
DK95111178T DK0680752T3 (da) 1991-04-11 1992-03-24 Konditionerede vandopløselige stoffer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK92907877.2T DK0580648T3 (da) 1991-04-11 1992-03-24 Fremgangsmåde til konditionering af vandopløselige stoffer

Country Status (28)

Country Link
US (1) US5562923A (de)
EP (3) EP0580648B1 (de)
JP (2) JP3400999B2 (de)
KR (1) KR100216384B1 (de)
AT (2) ATE137671T1 (de)
AU (1) AU662519B2 (de)
BG (1) BG61474B1 (de)
CA (1) CA2106975C (de)
CZ (1) CZ286936B6 (de)
DE (2) DE69210601T2 (de)
DK (2) DK0580648T3 (de)
EE (1) EE02970B1 (de)
ES (2) ES2168322T3 (de)
FI (1) FI105388B (de)
GR (1) GR3020602T3 (de)
HK (1) HK52497A (de)
HU (1) HU211116B (de)
IE (1) IE921144A1 (de)
IS (1) IS3834A (de)
NO (1) NO311867B1 (de)
PL (1) PL168232B1 (de)
PT (1) PT680752E (de)
RO (1) RO115779B1 (de)
RU (1) RU2112507C1 (de)
SE (1) SE9101090D0 (de)
SG (1) SG43180A1 (de)
SK (1) SK280310B6 (de)
WO (1) WO1992018110A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
CA2213700C (en) 1995-02-28 2002-04-02 Hoechst Marion Roussel, Inc. Pharmaceutical composition for piperidinoalkanol compounds
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
CN1149076C (zh) * 1997-03-20 2004-05-12 先灵公司 粉末附聚物的制备方法
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
CZ295461B6 (cs) * 1997-08-26 2005-08-17 Aventis Pharmaceuticals Inc. Farmaceutický prostředek ve formě dvouvrstvé tablety
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
DK1019021T4 (da) * 1997-09-29 2013-01-07 Novartis Ag Stabiliserede præparater til anvendelse i inhalatorer med afmålt dosis
FI105074B (fi) 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
GB9826286D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826284D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US20040028746A1 (en) * 2002-08-06 2004-02-12 Sonke Svenson Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
US20040247689A1 (en) * 2003-03-26 2004-12-09 Guy Samburski Process for preparing a pharmaceutical active ingredient with high specific surface area
PT1820494E (pt) * 2003-06-13 2010-04-14 Skendi Finance Ltd Microesferas de estradiol e de colesterol
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
WO2005037539A1 (en) * 2003-10-17 2005-04-28 E.I. Dupont De Nemours And Company Adhesion of foil to thermoplastic polymers
CA2554927A1 (en) * 2004-02-03 2005-08-18 Chemagis Ltd. Stable amorphous forms of montelukast sodium
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
DE102004048390A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
PL2234595T3 (pl) * 2007-12-13 2013-04-30 Novartis Ag Sposób zmniejszania tendencji soli glikopironiowej do agregacji podczas składowania
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
IN2014MN00023A (de) 2011-06-29 2015-06-12 Astrazeneca Ab
CA2905542C (en) * 2013-03-15 2022-05-03 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978192A (en) * 1971-09-23 1976-08-31 Sussman Martin V Method of drawing fibers using a microterraced drawing surface
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
EP0258258B1 (de) * 1985-06-21 1989-03-29 Gergely, Gerhard, Dr. Verfahren und vorrichtung zur behandlung von prozessgut, sowie mit hilfe des verfahrens und/oder der vorrichtung hergestelltes reaktivprodukt
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
CA2030581C (en) * 1989-11-24 2000-06-27 Gunther Atzl Pancreatin preparations
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles

Also Published As

Publication number Publication date
US5562923A (en) 1996-10-08
SK108893A3 (en) 1994-03-09
FI934429A (fi) 1993-10-08
DK0580648T3 (da) 1996-09-16
EP0580648B1 (de) 1996-05-08
HU211116B (en) 1995-10-30
ES2086733T3 (es) 1996-07-01
RO115779B1 (ro) 2000-06-30
BG98147A (bg) 1994-12-02
EP0680752B1 (de) 2001-11-14
AU662519B2 (en) 1995-09-07
PT680752E (pt) 2002-05-31
HK52497A (en) 1997-05-02
NO311867B1 (no) 2002-02-11
IS3834A (is) 1992-10-12
SG43180A1 (en) 1997-10-17
FI105388B (fi) 2000-08-15
CA2106975C (en) 2002-03-19
ES2168322T3 (es) 2002-06-16
KR100216384B1 (ko) 1999-08-16
EP0680752A2 (de) 1995-11-08
EP0580648A1 (de) 1994-02-02
DE69232207T2 (de) 2002-08-01
ATE208613T1 (de) 2001-11-15
SK280310B6 (sk) 1999-11-08
PL168232B1 (pl) 1996-01-31
SE9101090D0 (sv) 1991-04-11
CZ286936B6 (cs) 2000-08-16
CA2106975A1 (en) 1992-10-12
EP0508969A1 (de) 1992-10-14
BG61474B1 (en) 1997-09-30
NO933575L (no) 1993-10-06
DE69210601T2 (de) 1996-10-02
JPH06506454A (ja) 1994-07-21
HUT65095A (en) 1994-04-28
NO933575D0 (no) 1993-10-06
IE921144A1 (en) 1992-10-21
DE69210601D1 (de) 1996-06-13
RU2112507C1 (ru) 1998-06-10
HU9302870D0 (en) 1993-12-28
JP2003155228A (ja) 2003-05-27
JP3400999B2 (ja) 2003-04-28
EP0680752A3 (de) 1995-11-22
FI934429A0 (fi) 1993-10-08
ATE137671T1 (de) 1996-05-15
CZ211693A3 (en) 1994-04-13
WO1992018110A1 (en) 1992-10-29
GR3020602T3 (en) 1996-10-31
EE02970B1 (et) 1997-04-15
DE69232207D1 (de) 2001-12-20
AU1534792A (en) 1992-11-17

Similar Documents

Publication Publication Date Title
DK0680752T3 (da) Konditionerede vandopløselige stoffer
RU93058260A (ru) Способ получения водорастворимых микронизированных веществ
ATE117201T1 (de) Antimykotische zusammensetzung in trocken aerosol form.
FI852490L (fi) Genom inandning aktiverbar doseringsanordning.
CA2211600A1 (en) Apparatus for and method of testing leakage of hollow member
CA2049870A1 (en) System for expelling volatile impurities from groundwater
MY100201A (en) Water-dilutable wood-preserving liquids
AU2283899A (en) Method for drying a hollow body and implementing device
NO980861L (no) Granulat med risleevne og basert på organiske syrer, fremgangsmåte for fremstilling, samt anvendelse
IT7885588A0 (it) Mezzo propellente adinfiammabilita' ridotta per aerosol, procedimento per la suaproduzione e dispositivo per la realizzazione del procedimento.
JPS5259212A (en) Vehicle use air cleaner
RU96109577A (ru) Способ проведения оксигенобаротерапии в барокамерах с автономной системой дыхания
JPS526738A (en) Crosslinkable coating materials
JPS5232042A (en) Method to prevent polyethylene cross-linked with organosilane from deg radation
JPS644608A (en) Heat-treated fluorinated polymeric compound
JPS51137073A (en) A liquid pressure control apparatus
JPS5288279A (en) Stabilizer for organic materials
JPS528670A (en) Organic solvent vapor degreasing tabk
ES239975U (es) Dispositivo para el armado de habitaculos portatiles
BR7401345U (pt) Recipiente hermético provido de um sistema de carga e descarga regulável